News & Insights

Oxford Technology & Innovations EIS Fund (OTIF) invests £350k in Series A funding in Cambridge cancer diagnostics company Biofidelity Ltd

  • Biofidelity Ltd is commercialising a novel molecular diagnostic technology that enables oncologists to target the most effective treatment to each individual patient and to monitor patients for response to treatments and recurrence of disease.
  • OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a $12m Series A round led by BlueYard Capital, a Berlin-based venture capital firm.
  • This is the second OTIF investment in Biofidelity to date, bringing total funds invested by OTIF in the Company to £435k, in addition to investment in the technology through support of former parent company, Base4 Innovation Ltd.
Read post

Oxford Technology & Innovations EIS Fund (OTIF) invests £1.2m in Series B funding into University of Oxford spinout company Oxford Flow Ltd

  • Oxford Flow Ltd is commercialising a range of novel flow regulating valves for oil, gas, water and industrial process industries.
  • OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a £9.1m round which included strategic investment from GF Piping Systems.
  • This is the second OTIF investment in Oxford Flow Ltd to date, bringing total funds invested by OTIF in the company to £1.7m.
Read post

Oxford Technology & Innovations EIS Fund (OTIF) invests £300,006 into University of Oxford spinout company Oxehealth Ltd

  • Oxehealth Ltd is commercialising world-leading clinically-validated remote patient monitoring technology.
  • OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a £5m round led by existing shareholders.
  • This is third OTIF investment in Oxehealth Ltd to date, bringing total funds invested by OTIF in the Company to £800,013.
Read post